Blog

In 2026, choosing between Restasis and Xiidra for chronic dry eye involves balancing clinical speed against significant cost changes under Medicare Part D. Cost Cap: Medicare beneficiaries now benefit from a $2,100 annual out-of-pocket limit for all covered drugs. Generic Availability: Generic Restasis (cyclosporine) is widely available on lower insurance tiers, offering the lowest out-of-pocket…